A review of potential bluetongue virus vaccine strategies

Christie Mayo, Justin Lee, Jennifer Kopanke, Nigel J Maclachlan

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Bluetongue (BT) is an economically important, non-zoonotic arboviral disease of certain wild and domestic species of cloven-hooved ungulates. Bluetongue virus (BTV) is the causative agent and the occurrence of BTV infection is distinctly seasonal in temperate regions of the world, and dependent on the presence of vector biting midges (e.g. Culicoides sonorensis in much of North America). In recent years, severe outbreaks have occurred throughout Europe and BTV is endemic in most tropical and temperate regions of the world. Several vaccines have been licensed for commercial use, including modified live (live-attenuated) and inactivated products, and this review summarizes recent strategies developed for BTV vaccines with emphasis on technologies suitable for differentiating naturally infected from vaccinated animals. The goal of this review is to evaluate realistic vaccine strategies that might be utilized to control or prevent future outbreaks of BT.

Original languageEnglish (US)
JournalVeterinary Microbiology
StateAccepted/In press - Oct 11 2016


  • Bluetongue virus vaccine
  • Novel vaccine platforms

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)


Dive into the research topics of 'A review of potential bluetongue virus vaccine strategies'. Together they form a unique fingerprint.

Cite this